Here are the DEF 14A proxy statements from AIM ImmunoTech Inc. (AIM) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A DEF 14A covers the proxy statement, with executive pay and the shareholder votes, so if you follow AIM and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AIM filings page.
AIM ImmunoTech Inc. is seeking shareholder votes at its virtual annual meeting, scheduled for November 17, 2026, on five director nominees, the ratification of BDO USA, P.C. as its independent registered public accounting firm for fiscal 2026, and non-binding advisory approval of named executive officer compensation. The nominees are Nancy K. Bryan, David I. Chemerow, Thomas K. Equels, Ted D. Kellner and William M. Mitchell. The Board recommends voting FOR all three proposals.
Approximately 39,894,844 shares were outstanding and entitled to vote as of September 28, 2026, with one vote per share. A quorum requires holders of 33 and 1/3% of those shares to be present virtually or by proxy. BDO’s total fees were $826,650 for 2025 and $814,790 for 2024. The meeting will be held by live webcast, with preregistration required by November 16, 2026.
AIM ImmunoTech Inc. has called a virtual special stockholder meeting on July 15, 2026 to approve several financing-related actions and a potential reverse stock split. Holders of 27,724,245 shares of common stock as of June 15, 2026 may vote.
Stockholders are asked to approve issuances of more than 19.99% of outstanding shares tied to Class H, I and J warrants and to conversions of two promissory notes, in each case to comply with NYSE American Company Guide Sections 713(a) and 713(b). The company discloses that full cash exercises of these warrants could bring in additional gross proceeds of about $8.9 million (Class H), $4.9 million (Class I) and $5.3 million (Class J).
Another proposal would authorize the board, at its option, to implement a reverse stock split at a ratio of up to 1-for-25. The proxy explains that existing cash and investments are not expected to fund 12 months of operations and states that failure to raise additional capital in the very near term could force substantial cutbacks or even a voluntary bankruptcy filing. The board unanimously recommends voting “FOR” all seven proposals.